Company / Cash per Share
Moderna Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$6.72
FY2025
5-year range
$5.04 / $16.99
FY2021-FY2025
Trend
+33.3%
vs FY2024
Sector context
#32 of 205
Health Care
What the data says
Moderna's cash per share of $6.72 is higher than 84% of companies in the Health Care sector (FY2025). Cash per Share returned to growth in FY2025 after 2 years of decline, reaching $6.72.
Based on SEC 10-K filings.
6.72 in FY2025 with a 5-year CAGR of -2.9%. Top quartile in the Health Care sector.
Declined from $7.55 to $6.72 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -26.6%
- 5-Year CAGR
- -2.9%
- 10-Year CAGR
- -
Sector benchmark
Top 16% in Health CareTop 16% of 205This company $6.72 Sector average $72.93
▼
-90.8% below sector average
Key checks
Key Insights
- In FY2025, cash per share increased 33.3% year-over-year.
- Ranks #32 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2022.
- Lowest cash per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.72 | +33.3% |
| FY2024 | $5.04 | -33.2% |
| FY2023 | $7.55 | -55.6% |
| FY2022 | $16.99 | +158.4% |
| FY2021 | $6.58 | -15.7% |
| FY2020 | $7.80 | +986.3% |
| FY2019 | $0.72 | -92.9% |
| FY2018 | $10.10 | +382.9% |
| FY2017 | $2.09 | +153.6% |
| FY2016 | $0.82 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026